| Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer M Xing, AS Alzahrani, KA Carson, D Viola, R Elisei, B Bendlova, L Yip, ... Jama 309 (14), 1493-1501, 2013 | 1078 | 2013 |
| Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis M Paul, V Shani, E Muchtar, G Kariv, E Robenshtok, L Leibovici Antimicrobial agents and chemotherapy 54 (11), 4851-4863, 2010 | 873 | 2010 |
| Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer M Xing, AS Alzahrani, KA Carson, YK Shong, TY Kim, D Viola, R Elisei, ... Journal of clinical oncology 33 (1), 42-50, 2015 | 633 | 2015 |
| Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis E Robenshtok, A Gafter-Gvili, E Goldberg, M Weinberger, M Yeshurun, ... Journal of Clinical Oncology 25 (34), 5471-5489, 2007 | 391 | 2007 |
| Treatment modalities for Graves’ ophthalmopathy: systematic review and metaanalysis H Stiebel-Kalish, E Robenshtok, M Hasanreisoglu, D Ezrachi, I Shimon, ... The Journal of Clinical Endocrinology & Metabolism 94 (8), 2708-2716, 2009 | 247 | 2009 |
| Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients E Robenshtok, S Fish, A Bach, JM Domínguez, A Shaha, RM Tuttle The Journal of Clinical Endocrinology & Metabolism 97 (8), 2706-2713, 2012 | 189 | 2012 |
| Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials D Shefet, E Robenshtok, M Paul, L Leibovici Archives of internal medicine 165 (17), 1992-2000, 2005 | 165 | 2005 |
| Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis S Dvorkin, E Robenshtok, D Hirsch, Y Strenov, I Shimon, CA Benbassat The Journal of Clinical Endocrinology & Metabolism 98 (6), 2409-2414, 2013 | 150 | 2013 |
| Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists Y Greenman, O Cooper, I Yaish, E Robenshtok, N Sagiv, T Jonas-Kimchi, ... European journal of endocrinology 175 (1), 63-72, 2016 | 139 | 2016 |
| Empiric antibiotic coverage of atypical pathogens for community‐acquired pneumonia in hospitalized adults N Eliakim‐Raz, E Robenshtok, D Shefet, A Gafter‐Gvili, L Vidal, M Paul, ... Cochrane Database of Systematic Reviews, 2012 | 136 | 2012 |
| The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes E Robenshtok, M Paul, L Leibovici, A Fraser, S Pitlik, I Ostfeld, Z Samra, ... Journal of Hospital Infection 64 (3), 282-287, 2006 | 123 | 2006 |
| Adverse reaction to atropine and the treatment of organophosphate intoxication. E Robenshtok, S Luria, Z Tashma, A Hourvitz The Israel Medical Association Journal: IMAJ 4 (7), 535-539, 2002 | 117 | 2002 |
| Even without additional therapy, serum thyroglobulin concentrations often decline for years after total thyroidectomy and radioactive remnant ablation in patients with … RP Padovani, E Robenshtok, M Brokhin, RM Tuttle Thyroid 22 (8), 778-783, 2012 | 111 | 2012 |
| Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test C Block, E Robenshtok, A Simhon, M Shapiro Journal of Hospital Infection 46 (2), 147-152, 2000 | 101 | 2000 |
| Empirical antifungal therapy for patients with neutropenia and persistent fever: systematic review and meta-analysis E Goldberg, A Gafter-Gvili, E Robenshtok, L Leibovici, M Paul European Journal of Cancer 44 (15), 2192-2203, 2008 | 99 | 2008 |
| Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study E Robenshtok, G Tzvetov, S Grozinsky-Glasberg, I Shraga-Slutzky, ... Thyroid 21 (1), 43-48, 2011 | 98 | 2011 |
| Long-term outcomes and prognostic factors in patients with differentiated thyroid cancer and distant metastases D Hirsch, S Levy, G Tsvetov, A Gorshtein, I Slutzky-Shraga, A Akirov, ... Endocrine Practice 23 (10), 1193-1200, 2017 | 85 | 2017 |
| Recombinant human thyroid stimulating hormone–assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence J Hugo, E Robenshtok, R Grewal, S Larson, RM Tuttle Thyroid 22 (10), 1007-1015, 2012 | 83 | 2012 |
| Impact of minimal extrathyroid extension in differentiated thyroid cancer: systematic review and meta-analysis T Diker-Cohen, D Hirsch, I Shimon, G Bachar, A Akirov, H Duskin-Bitan, ... The Journal of Clinical Endocrinology & Metabolism 103 (6), 2100-2106, 2018 | 81 | 2018 |
| A low postoperative nonstimulated serum thyroglobulin level does not exclude the presence of radioactive iodine avid metastatic foci in intermediate-risk differentiated thyroid … E Robenshtok, RK Grewal, S Fish, M Sabra, RM Tuttle Thyroid 23 (4), 436-442, 2013 | 80 | 2013 |
